Bristol-Meyers Squibb

Bristol-Myers Squibb’s unparalleled drug pipeline in rapidly growing therapeutic areas will drive share price appreciation over the medium term.

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Their medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis, and others. BMY has built a sustainable pipeline of potential therapies and continue to leverage translational medicine and data analytics to understand how they can deliver the right medicine to the right patient at the right time to achieve the best outcome.